PARIS (Reuters) - French health group Sanofi said on Friday that if it decided to bid for biotech company Horizon Therapeutics Plc, it would do so in .
Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace
AstraZeneca is acquiring TeneoTwo in a $100 million bet on that biotech’s lymphoma drug candidate, which is designed to go after two targets. It’s the latest deal made by a big pharmaceutical company looking to get its hands on a new type of cancer therapy called a T cell engager.
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1 Paris, April 28, 2022 Q1 2022 sales growth of 8.6% at CER driven by Dupixent and CHC
Investegate announcements from Sanofi - Aventis Groupe, Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatment